Coeptis Therapeutics Holdings, Inc. (COEPW) Stock Price, Financials & Summary

Price chart

Mar 25Mar 30Apr 2Apr 8Apr 13Apr 16Apr 21Apr 24

Key dataApr 24, 2026

Open$0.01

From 52W high−76.68%

Volume4.63M

Market cap$49348.93

P/E (TTM)—

P/S (TTM)0.0x

Div yield—

Key dataApr 24, 2026

Open

$0.01

From 52W high

−76.68%

Volume

4.63M

Market cap

$49348.93

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

0.4x

P/E (TTM)

—

RSI (14)

46.2

MomentumView details →

1D Return

+0.00%

YTD Return

−3.70%

SummaryUpdated Mar 1, 2026

Coeptis Therapeutics Holdings, Inc. (OTCMKTS:COEPW) is a biopharmaceutical company founded in 2017 and headquartered in Wexford, Pennsylvania. The company focuses on developing and commercializing both generic and branded pharmaceutical products, with a particular emphasis on innovative cell therapy platforms designed to treat various forms of cancer. Since its inception, Coeptis has evolved from a traditional pharmaceutical company into a biotechnology firm specializing in cutting-edge immunotherapy treatments, particularly those targeting specific cancer cell markers.

Ask drillr about Coeptis Therapeutics Holdings, Inc. →

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

0.4x

EV/Sales

−3.3x

P/S (TTM)

0.0x

P/B (TTM)

0.0x

ProfitabilityView details →

Gross Margin

87.23%

Net Margin

−839.69%

EBITDA Margin

−769.03%

ROE (TTM)

−69.12%

ROA (TTM)

−60.00%

Asset Turnover

0.07x

GrowthView details →

Revenue YoY

+2148.85%

EPS YoY

—

FCF YoY

−12.41%

Revenue CAGR 3Y

—

EPS CAGR 3Y

+50.27%

EBITDA YoY

−9.44%

MomentumView details →

1D Return

+0.00%

YTD Return

−3.70%

1Y Return

−48.00%

RSI (14)

46.2

vs 50D SMA

−9.39%

vs 200D SMA

−44.98%

Capital & dividendView details →

Debt/Equity

0.01x

Current Ratio

3.25x

Quick Ratio

3.25x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.28

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

1.41M

Net Income (TTM)

−11.87M

Op. CF (TTM)

−8.00M

Latest newsMore news →

Paradox Data LLC leased its building and approximately three-acre parcel in El Dorado, Arkansas to Paradox Infrastructure LLC for continued bitcoin mining operations at $1.00 per year base rent, with Z Squared Inc. liable for a one-time $500,000 relocation payment.35d ago

Similar companies

Celularity Inc.CELUW Instinct Bio Technical Company Holdings Inc. WarrantsBIOTW SeaStar Medical Holding CorporationICUCW Revelation Biosciences, Inc.REVBW Vincerx Pharma, Inc.VINC SAB Biotherapeutics, Inc.SABSW Find similar companies →

Latest newsMore news →

Investors filed a complaint against Broad Street Global Management LLC, BROADSTREET INC., and three individual fund operators alleging misuse of fund assets and an attempt to force investors into restricted stock instead of honoring cash redemptions.6d ago Paradox Data LLC leased its building and approximately three-acre parcel in El Dorado, Arkansas to Paradox Infrastructure LLC for continued bitcoin mining operations at $1.00 per year base rent, with Z Squared Inc. liable for a one-time $500,000 relocation payment.35d ago